James Liu
Research Scientist ImmuneBridge
James Liu earned his BS in Microbiology from the University of Wisconsin–Madison and an MS in Immunology from the University of Southern California. James initially joined ImmuneBridge to help optimize NK cell differentiation from hematopoietic stem cells. He then continued his work in immuno-oncology at Revolution Medicines, where he investigated the effects of RAS inhibitors on the tumor microenvironment. James is now back at ImmuneBridge, focused on advancing our innovative therapies through large-scale manufacturing and multiplexed donor screening.
Seminars
Advancing cell and gene therapies from preclinical to clinical stages requires tackling critical manufacturing hurdles. Donor variability, cryopreservation, scalability, and equipment choices, including the use of bioreactors, all impact product quality, reproducibility, and regulatory readiness. This workshop explores practical strategies to strengthen manufacturing systems, mitigate risk, and ensure a smooth transition into the clinic.
Join this workshop to:
- Understand how donor variability and cryopreservation affect product quality, and ways to reduce these risks
- Explore scalability, bioreactor implementation, and equipment decisions that drive consistency and compliance
- Review case-based approaches for moving from preclinical data to robust clinical programs
